Shares of ESSA Pharma (NASDAQ: EPIX) have tanked 22% in the past month, while the short interest in the stock stood at 4.5%. However, shares have been on an upswing in the past five days, going up by 11.6% following corporate insiders' buying of the stock. EPIX is a clinical-stage pharmaceutical company that develops novel therapies for the treatment of prostate cancer. The pharma company has seen an uptick in insider interest with BB Biotech AG, holding a more than 10% stake in EPIX, loading up on its shares. BB Biotech bought shares worth $945,000 on July 20 and $1.7 million on July 18, respectively.
https://www.tipranks.com/news/article/epix-stock-gains-11-6-on-insider-buys?utm_source=advfn.com&utm_medium=referral
ESSA Pharma (NASDAQ:EPIX)
Gráfico Histórico do Ativo
De Set 2022 até Out 2022 Click aqui para mais gráficos ESSA Pharma.
ESSA Pharma (NASDAQ:EPIX)
Gráfico Histórico do Ativo
De Out 2021 até Out 2022 Click aqui para mais gráficos ESSA Pharma.